Birmingham Health Partners plays key role in report calling for Government reform of regulation of medical devices
Experts within Birmingham Health Partners (BHP) have significantly contributed to a new independent report calling on the UK Government to reform the regulation of medical devices.
A new clinical study, investigating the best gap between first and second COVID-19 vaccine doses for pregnant women, is now open to recruitment.
West Midlands-led trial finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised COVID-19 patients
Results from the RECOVERY-RS trial, which assessed different ways to provide oxygen support for patients in hospital with COVID-19, have found that continuous positive airway pressure (CPAP) reduced the need for invasive mechanical ventilation.
Researchers have published the first findings on the diagnosis of patients with vaccine-induced immune thrombocytopenia and thrombosis (VITT), a new thrombotic syndrome associated with the COVID-19 vaccine.
UHB and Cambridge University Hospitals win government funding for ground-breaking AI in radiotherapy
A machine learning technology that helps cut the time patients wait for life-saving cancer treatment has been successful in the latest round of the Artificial Intelligence in Health and Care Award
A trial to find out if kidney patients can benefit from additional protection from COVID-19, using a drug routinely used to treat tapeworm, is rolling out across the UK